A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension

Journal of Human Hypertension

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Andersson, O K ^a   Neldam, S ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Candesartan cilexetil; Clinical study; Hypertension; Losartan

Indexed keywords

CANDESARTAN HEXETIL; LOSARTAN; PLACEBO;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0030661711     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Eberhardt RT, Kevak RM, Kang PM, Frishman WH. Angiotensin II receptor blockade: An innovative approach to cardiovascular pharmacotherapy. J Clin Pharmacol 1993; 33: 1023-1038.
2. Gradman AH et al. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25: 1345-1350.
3. Elliot HL. Trough : peak ratio and twenty-four-hour blood pressure control, J Hypertens 1994; 12 (Suppl 5): 29S-33S.